Auteurs
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Auteurs » - entrée « Mauro Galeazzi »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Mauro De Rosa < Mauro Galeazzi < Mauro Keiserman  Facettes :

List of bibliographic references indexed by Mauro Galeazzi

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
001693 (2017) Serena Colafrancesco [Italie] ; Roberta Priori [Italie] ; Guido Valesini [Italie] ; Lorenza Argolini [Italie] ; Elena Baldissera [Italie] ; Elena Bartoloni [Italie] ; Daniele Cammelli [Italie] ; Giovanni Canestrari [Italie] ; Luca Cantarini [Italie] ; Elena Cavallaro [Italie] ; Giulio Cavalli [Italie] ; Lucia Cerrito [Italie] ; Paola Cipriani [Italie] ; Lorenzo Dagna [Italie] ; Ginevra De Marchi [Italie] ; Salvatore De Vita [Italie] ; Giacomo Emmi [Italie] ; Gianfranco Ferraccioli [Italie] ; Micol Frassi [Italie] ; Mauro Galeazzi [Italie] ; Roberto Gerli [Italie] ; Roberto Giacomelli [Italie] ; Elisa Gremese [Italie] ; Florenzo Iannone [Italie] ; Giovanni Lapadula [Italie] ; Giuseppe Lopalco [Italie] ; Raffaele Manna [Italie] ; Alessandro Mathieu [Italie] ; Carlomaurizio Montecucco [Italie] ; Marta Mosca [Italie] ; Ilaria Piazza [Italie] ; Matteo Piga [Italie] ; Irene Pontikaki [Italie] ; Micol Romano [Italie] ; Silvia Rossi [Italie] ; Maurizio Rossini [Italie] ; Piero Ruscitti [Italie] ; Elena Silvestri [Italie] ; Chiara Stagnaro [Italie] ; Rosaria Talarico [Italie] ; Angela Tincani [Italie] ; Ombretta Viapiana [Italie] ; Gianfranco Vitiello [Italie] ; Francesca Fabris [Italie] ; Sara Bindoli [Italie] ; Leonardo Punzi [Italie] ; Paola Galozzi [Italie] ; Paolo Sfriso [Italie]Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study
001697 (2017) Rieke Alten [Allemagne] ; Xavier Mariette [France] ; Hanns-Martin Lorenz [Allemagne] ; Mauro Galeazzi [Italie] ; Alain Cantagrel [France] ; Hubert G. Nü Lein [Allemagne] ; Melanie Chartier [France] ; Yedid Elbez [France] ; Christiane Rauch [Allemagne] ; Manuela Le Bars [France]Real-world predictors of 12–month intravenous abatacept retention in patients with rheumatoid arthritis in the ACTION observational study
001797 (2017) Giuseppe Lopalco [Italie] ; Claudia Fabiani [Italie] ; Jurgen Sota [Italie] ; Orso Maria Lucherini [Italie] ; Gian Marco Tosi [Italie] ; Bruno Frediani [Italie] ; Florenzo Iannone [Italie] ; Mauro Galeazzi [Italie] ; Rossella Franceschini [Italie] ; Donato Rigante [Italie] ; Luca Cantarini [Italie]IL-6 blockade in the management of non-infectious uveitis.
001B08 (2016) Antonio Vitale [Italie] ; Donato Rigante [Italie] ; Giuseppe Lopalco [Italie] ; Giacomo Emmi [Italie] ; Maria Teresa Bianco [Italie] ; Mauro Galeazzi [Italie] ; Florenzo Iannone [Italie] ; Luca Cantarini [Italie]New therapeutic solutions for Behçet's syndrome.
001B90 (2016) Florenzo Iannone [Italie] ; Giuseppe Lopalco [Italie] ; Luca Cantarini [Italie] ; Mauro Galeazzi [Italie] ; Giovanni Lapadula [Italie]Efficacy and safety of combination therapy for preventing bone damage in rheumatoid arthritis.
001C88 (2016) Antonio Vitale [Italie] ; Antonella Insalaco [Italie] ; Paolo Sfriso [Italie] ; Giuseppe Lopalco [Italie] ; Giacomo Emmi [Italie] ; Marco Cattalini [Italie] ; Raffaele Manna [Italie] ; Rolando Cimaz [Italie] ; Roberta Priori [Italie] ; Rosaria Talarico [Italie] ; Stefano Gentileschi [Italie] ; Ginevra De Marchi [Italie] ; Micol Frassi [Italie] ; Romina Gallizzi [Italie] ; Alessandra Soriano [Italie] ; Maria Alessio [Italie] ; Daniele Cammelli [Italie] ; Maria C. Maggio [Italie] ; Renzo Marcolongo [Italie] ; Francesco La Torre [Italie] ; Claudia Fabiani [Italie] ; Serena Colafrancesco [Italie] ; Francesca Ricci [Italie] ; Paola Galozzi [Italie] ; Ombretta Viapiana [Italie] ; Elena Verrecchia [Italie] ; Manuela Pardeo [Italie] ; Lucia Cerrito [Italie] ; Elena Cavallaro [Italie] ; Alma N. Olivieri [Italie] ; Giuseppe Paolazzi [Italie] ; Gianfranco Vitiello [Italie] ; Armin Maier [Italie] ; Elena Silvestri [Italie] ; Chiara Stagnaro [Italie] ; Guido Valesini [Italie] ; Marta Mosca [Italie] ; Salvatore De Vita [Italie] ; Angela Tincani [Italie] ; Giovanni Lapadula [Italie] ; Bruno Frediani [Italie] ; Fabrizio De Benedetti [Italie] ; Florenzo Iannone [Italie] ; Leonardo Punzi [Italie] ; Carlo Salvarani [Italie] ; Mauro Galeazzi [Italie] ; Donato Rigante [Italie] ; Luca Cantarini [Italie]A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study
001F30 (2015) Hubert G. Nü Lein [Allemagne] ; Rieke Alten [Allemagne] ; Mauro Galeazzi [Italie] ; Hanns-Martin Lorenz [Allemagne] ; Michael T. Nurmohamed [Pays-Bas] ; William G. Bensen [Canada] ; Gerd R. Burmester [Allemagne] ; Hans-Hartmut Peter [Allemagne] ; Karel Pavelka [République tchèque] ; Melanie Chartier [France] ; Coralie Poncet [France] ; Christiane Rauch [Allemagne] ; Manuela Le Bars [France]Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study
001F89 (2015) Giuseppe Lopalco [Italie] ; Luca Cantarini [Italie] ; Antonio Vitale [Italie] ; Florenzo Iannone [Italie] ; Maria Grazia Anelli [Italie] ; Laura Andreozzi [Italie] ; Giovanni Lapadula [Italie] ; Mauro Galeazzi [Italie] ; Donato Rigante [Italie]Interleukin-1 as a Common Denominator from Autoinflammatory to Autoimmune Disorders: Premises, Perils, and Perspectives
002119 (2015) Pietro Enea Lazzerini [Italie] ; Maurizio Acampa ; Pier Leopoldo Capecchi ; Irene Fineschi ; Enrico Selvi ; Valentina Moscadelli ; Stefania Zimbone ; Daniela Gentile ; Mauro Galeazzi ; Franco Laghi-PasiniAntiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation.
002365 (2014) Hubert G. Nü Lein [Allemagne] ; Rieke Alten [Allemagne] ; Mauro Galeazzi [Italie] ; Hanns-Martin Lorenz [Allemagne] ; Dimitrios Boumpas [Grèce] ; Michael T. Nurmohamed [Pays-Bas] ; William G. Bensen [Canada] ; Gerd R. Burmester [Allemagne] ; Hans-Hartmut Peter [Allemagne] ; Franz Rainer [Autriche] ; Karel Pavelka [République tchèque] ; Melanie Chartier [France] ; Coralie Poncet [France] ; Christiane Rauch [Allemagne] ; Manuela Le Bars [France]Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study
002494 (2014) Francesco Caso [Italie] ; Luisa Costa [Italie] ; Donato Rigante [Italie] ; Orso Maria Lucherini [Italie] ; Paolo Caso [Italie] ; Vittoria Bascherini [Italie] ; Bruno Frediani [Italie] ; Rolando Cimaz [Italie] ; Edoardo Marrani [Italie] ; Laura Nieves-Martín [Espagne] ; Mariangela Atteno [Italie] ; Carmela G L. Raffaele [Italie] ; Giusyda Tarantino [Italie] ; Mauro Galeazzi [Italie] ; Leonardo Punzi [Italie] ; Luca Cantarini [Italie]Biological treatments in Behçet's disease: beyond anti-TNF therapy.
003F79 (2009) Luca Cantarini [Italie] ; Orso Maria Lucherini [Italie] ; Gabriele Simonini [Italie] ; Mauro Galeazzi [Italie] ; Cosima Tatiana Baldari [Italie] ; Rolando Cimaz [Italie]Systemic-onset juvenile idiopathic arthritis complicated by early onset amyloidosis in a patient carrying a mutation in the MEFV gene
004295 (????) Antonella Fioravanti [Italie] ; Sara Tenti [Italie] ; Maria Romana Bacarelli [Italie] ; Arianna Damiani [Italie] ; Francesca Li Gobbi [Italie] ; Francesca Bandinelli [Italie] ; Sara Cheleschi [Italie] ; Mauro Galeazzi [Italie] ; Maurizio Benucci [Italie]Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibition.
004418 (????) Chiara Giannitti [Italie] ; Irene Fineschi ; Bruno Frediani ; Antonella Fioravanti ; Mauro GaleazziEfficacy and safety of tocilizumab combined with cyclosporine A in a patient with rheumatoid arthritis and concomitant chronic hepatitis C virus infection.
004443 (????) Florenzo Iannone [Italie] ; Marilina Tampoia [Italie] ; Margherita Giannini [Italie] ; Giuseppe Lopalco [Italie] ; Luca Cantarini [Italie] ; C Danilo Villalta [Italie] ; Mauro Galeazzi [Italie] ; Giovanni Lapadula [Italie]Changes in anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes serum levels in patients with rheumatoid arthritis following treatment with different biological drugs.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Mauro Galeazzi" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Mauro Galeazzi" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Mauro Galeazzi
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021